Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pharmasset provides new data on HCV candidate PSI-7851

Jan. 15, 2010

Phase III studies show comparable efficacy with albinterferon alfa-2b vs. peginterferon alfa-2a

Jan. 14, 2010

Durable viral suppression seen with MK-7009 combination therapy in patients with hepatitis C

Jan. 14, 2010

Pharmacokinetics of HCV protease inhibitor ABT-450 assessed with and without ritonavir

Jan. 14, 2010

INX-189 displays potent inhibitory activity against HCV in vitro

Jan. 13, 2010

Milk thistle extract silibinin shows potent activity in in patients with hepatitis C

Jan. 13, 2010

In vitro data clarify mechanism of action of HCV candidate ATI-0810

Jan. 12, 2010

Hepatitis C treatment SPC-3649 to enter phase II investigation this year

Jan. 12, 2010

Study determines pharmacokinetics of HCV candidate ABT-333 in infected patients

Jan. 12, 2010

BIT-225 shows modest antiviral efficacy in phase Ib trial in hepatitis C

Jan. 11, 2010

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...